Search images on Google      Product Monograph

Active Ingredients:

• alemtuzumab, 12 MG/1.2 ML

DIN: 02418320

Dosage Form(s): SOLUTION

Route(s) of Administration: INTRAVENOUS

Description: CONCENTRATE FOR SOLUTION FOR IV INFUSION. SINGLE-USE VIAL.

Schedule: Prescription

Company: SANOFI GENZYME, A DIVISION OF SANOFI-AVENTIS CANADA INC

ATC:

• L04 - IMMUNOSUPPRESSANTS (ATC, WHO, Wiki)
• L04A - IMMUNOSUPPRESSANTS (ATC, WHO)
• L04AG - (ATC, WHO)
• L04AG06 - ALEMTUZUMAB (WHO)

Packaging:

• Package size unit: No information
• Package type: No information
• Package size: No information
• Product information: 1.2ML/VIAL

 

External Links for Lemtrada:

Search on Google

• Lemtrada side effects
• Lemtrada dosage
• alemtuzumab side effects
• alemtuzumab dosage